Abstract:For the development of highly effective and low‐toxic radiosensitizers, herein, the study develops a nano‐heterojunction (Se@PB) containing Fe2+‐Se‐Fe3+ electron transfer chains, which is inspired by the high safety of the trace elements selenium (Se) and Prussian blue (PB), and the unique activities of Se in strong electron contribution and its redox properties. The Se@PB nano‐heterojunction containing Fe2+‐Se‐Fe3+ chain exerts physical and biochemical radiosensitization by accelerating electron transfer and redox dyshomeostasis. Exploring efficient and low‐toxicity radiosensitizers to break through the bottleneck of radiation tolerance, immunosuppression and poor prognosis remains one of the critical developmental challenges in radiotherapy. Nanoheterojunctions, due to their unique physicochemical properties, have demonstrated excellent radiosensitization effects in radiation energy deposition and in lifting tumor radiotherapy inhibition. Herein, they doped selenium (Se) into prussian blue (PB) to construct a nano‐heterojunction (Se@PB), which could promote the increase of Fe2+/Fe3+ ratio and conversion of Se to a high valence state with Se introduction. The Fe2+‐Se‐Fe3+ electron transfer chain accelerates the rate of electron transfer on the surface of the nanoparticles, which in turn endows it with efficient X‐ray energy transfer and electron transport capability, and enhances radiotherapy physical sensitivity. Furthermore, Se@PB induces glutathione (GSH) depletion and Fe2+ accumulation through pro‐Fenton reaction, thereby disturbs the redox balance in tumor cells and enhances biochemical sensitivity of radiotherapy. As an excellent radiosensitizer, Se@PB effectively enhances X‐ray induced mitochondrial dysfunction and DNA damage, thereby promotes cell apoptosis and synergistic cervical cancer radiotherapy. This study elucidates the radiosensitization mechanism of Se‐doped nanoheterojunction from the perspective of the electron transfer chain and biochemistry reaction, which provides an efficient and low‐toxic strategy in radiotherapy.

Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics

Dual-function Nanosystem for Synergetic Cancer Chemo-/Radiotherapy Through ROS-mediated Signaling Pathways.

X-Ray-Responsive Selenium Nanoparticles for Enhanced Cancer Chemo-Radiotherapy

Cancer-targeted Selenium Nanoparticles Sensitize Cancer Cells to Continuous γ Radiation to Achieve Synergetic Chemo-Radiotherapy.

Selenium‐Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization

Functionalized Selenium Nanosystem As Radiation Sensitizer of 125I Seeds for Precise Cancer Therapy.

A multifunctional mesoporous silica drug delivery nanosystem that ameliorates tumor hypoxia and increases radiotherapy efficacy

Selenadiazole Derivatives As Theranostic Agents for Simultaneous Cancer Chemo-/Radiotherapy by Targeting Thioredoxin Reductase

Rational Design of Cancer-Targeted BSA Protein Nanoparticles As Radiosensitizer to Overcome Cancer Radioresistance

Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation

Selenium-containing Metallodrug Overcomes Cervical Cancer Radioresistance Through Physical-Chemical Dual Sensitization.

Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells.

Selenium-containing metallodrug overcomes cervical cancer radioresistance by physical-chemical dual sensitization

Doxorubicin and iron-doped mesoporous silica nanoparticles for chemodynamic therapy and chemotherapy of breast cancer

Selective Cellular Uptake and Induction of Apoptosis of Cancer-Targeted Selenium Nanoparticles.

Morphology-directed radiosensitization of MoSe2 nanoplatforms for promoting cervical cancer radiotherapy

Rational Design of Cancer-Targeted Selenadiazole Derivative As Efficient Radiosensitizer for Precise Cancer Therapy

Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy

Cancer cell membrane-coated siRNA-Decorated Au/MnO2 nanosensitizers for synergistically enhanced radio-immunotherapy of breast cancer

Enhancing Radiotherapy Sensitivity in Prostate Cancer with Lentinan-Functionalized Selenium Nanoparticles: Mechanistic Insights and Therapeutic Potential

Multifunctional Polyamidoamine-Modified Selenium Nanoparticles Dual-Delivering Sirna and Cisplatin to A549/DDP Cells for Reversal Multidrug Resistance.